Tissues contain distinct stem cell niches, but whether cell turnover is coordinated between niches during growth is unknown. Here, we report that in mouse skin, hair growth is accompanied by sebaceous gland and interfollicular epidermis expansion. During hair growth, cells in the bulge and outer root sheath temporarily upregulate the glutamate transporter SLC1A3, and the number of SLC1A3 + basal cells in interfollicular epidermis and sebaceous gland increases. Fate mapping of SLC1A3 + cells in mice revealed transient expression in proliferating stem/progenitor cells in all three niches. Deletion of slc1a3 delays hair follicle anagen entry, uncouples interfollicular epidermis and sebaceous gland expansion from the hair cycle, and leads to reduced fur density in aged mice, indicating a role of SLC1A3 in stem/progenitor cell activation. Modulation of metabotropic glutamate receptor 5 activity mimics the effects of SLC1A3 deletion or inhibition. These data reveal that stem/progenitor cell activation is synchronized over distinct niches during growth and identify SLC1A3 as a general marker and effector of activated epithelial stem/progenitor cells throughout the skin.
Introduction
Proliferation of tissue-specific stem and progenitor cells for production of differentiated progeny and stem cell renewal is the basis of organ growth and homeostasis. However, whether or how cell turnover is coordinated between distinct stem cell niches during growth is unknown. Skin contains distinct epithelial stem cell niches ( Fig 1A) . Hair follicles cycle through synchronized phases of rest (telogen), growth (anagen), and regression (catagen; Paus & Cotsarelis, 1999) , corresponding to activation of hair follicle stem cells. In contrast, in sebaceous gland (SG) and interfollicular epidermis (IFE), stem and progenitor cells continuously replace lost cells. Whether cell turnover in SG and IFE is influenced by the hair cycle and whether there is a common activity marker and effector is unclear.
Hair follicle stem cells in the bulge are quiescent in telogen but active during anagen (Fuchs & Nowak, 2008) . Anagen can be divided into six stages (I-VI; Muller-Rover et al, 2001) , with an initial expansion of the hair germ (HG), a brief activation of bulge CD34 + hair follicle stem cells and sustained proliferation of the outer root sheath (ORS) in which most actively cycling hair follicle stem cells are located (Hsu et al, 2011; Rompolas & Greco, 2014) . In the SG, proliferating basal cells continuously replace sebocytes, which produce sebum. There are several contradicting reports regarding the origin and self-renewing capacity of SG basal cells with the latest report pointing toward a self-sustained progenitor pool within the SG (Horsley et al, 2006; Snippert et al, 2010a; Page et al, 2013; Fullgrabe et al, 2015) . The IFE is sustained through stem and progenitor cells, located in the basal layer, which constantly replace lost keratinocytes. The degree of heterogeneity within the IFE stem and progenitor cell population is still under investigation (Schepeler et al, 2014) . Stem cell activation has been shown to involve chromatin remodeling and gene expression changes (Ezhkova et al, 2011; Lien et al, 2011) , and several transcription factors that govern nichespecific stem cell behavior have been identified (Horsley et al, 2008; Osorio et al, 2008; Genander et al, 2014) . The expression of these factors is controlled by extracellular signals. BMP signaling has been demonstrated to maintain quiescence, while Wnt signaling in the absence of BMP promotes activation of HF stem cells (Kobielak et al, 2007; Greco et al, 2009; Kandyba et al, 2013) .
Glutamate signaling is common to several stem cell niches (Julio-Pieper et al, 2011) . In Drosophila, dietary L-glutamate stimulates intestinal stem cell division and gut growth via the metabotropic glutamate receptor (Deng et al, 2015) . Neural stem cells express the metabotropic glutamate receptor 5 (mGluR5), the activity of which can impact proliferation and differentiation (Nochi et al, 2012; Xiao et al, 2013) . Glutamate receptor-mediated synaptic transmission is dependent on extracellular glutamate clearance, effectuated by glutamate transporters. The removal of glutamate in the proximity of glutamate receptors enables fast receptor deactivation, which determines the frequency in which new signaling events can be registered.
Here, we identify the glial high-affinity glutamate transporter Slc1a3, also known as EAAT1 or Glast, as a unifying marker of activated stem and progenitor cells in the hair follicle, IFE and SG. Using in vivo lineage tracing, we show that Slc1a3-expressing cells sustain all three epithelial compartments long-term, identifying them as stem or progenitor cells. All three epithelial compartments synchronize growth during anagen, temporarily increasing stem and progenitor cell activation and Slc1a3 expression. Deletion of Slc1a3 delays the onset of the growth phase, uncouples IFE and SG expansion from the hair cycle, and leads to reduced fur density over time. Slc1a3 acts in conjunction with mGluR5 and inhibition of Slc1a3 or mGluR5 delays growth phase onset and uncouples IFE and SG expansion from the hair cycle. These data reveal that stem/progenitor cell activation is synchronized A Schematic depiction of the telogen and anagen hair follicle including bulge, hair germ (HG), dermal papilla (DP), and outer root sheath (ORS). Adjacent to the hair follicle (HF) are sebaceous gland (SG) and interfollicular epidermis (IFE). B Proliferation of SG in relation to hair cycle (1 st telogen, n = 5, 95 HFs; 2 nd anagen, n = 7, 140 HFs, catagen n = 3, 60 HFs; 2 nd telogen, n = 4, 79 HFs; 3 rd anagen, n = 3, 60 HFs). C Proliferation of IFE in relation to hair cycle (1 st telogen, n = 7, 30 mm; 2 nd anagen, n = 6, 26 mm; catagen n = 7, 54 mm; 2 nd telogen, n = 7, 49 mm; 3 rd anagen, n = 3, 7 mm). D Growth of SG in relation to hair cycle (1 st telogen n = 5, 60 SGs; 2 nd anagen, n = 8, 131 SGs; catagen n = 3, 73 SGs; 2 nd telogen, n = 6, 60 SGs; 3 rd anagen, n = 3, 60
SGs). E Growth of IFE in relation to hair cycle (1 st telogen, n = 5, 9 mm; 2 nd anagen, n = 5, 8 mm; catagen n = 7, 54 mm; 2 nd telogen, n = 7, 48 mm; 3 rd anagen, n = 3, 5 mm). F Slc1a3 mRNA expression in hair follicle stem cells (HFSCs) during growth (anagen) compared to rest (telogen; two technical replicates; anagen, n = 4; telogen, n = 7). G, H Slc1a3-CreER T2 is absent in telogen hair follicles (G) but expressed in HG, bulge, and ORS during anagen (H).
I-L Slc1a3-CreER T2 is expressed in SG basal cells (I) but not in sebocytes (J) and in IFE scattered basal (K) and most suprabasal cells (L).
M
Percentage of Slc1a3-CreER T2+ basal cells in SG during telogen (n = 3, 63 SGs) compared to anagen (n = 3, 59 SGs). N Percentage of Slc1a3-CreER T2+ basal cells in IFE during telogen (n = 4, 9 mm) compared to anagen (n = 3, 6 mm).
Data information: Data presented as mean AE SEM in (C, F, N) and mean AE SEM in (E). Box-and-whisker plots: midline depicts the median; box depicts 25 th and 75 th percentiles, and whiskers are plotted according to Tukey with dots marking outliers in (B and D) or depict the minimum and maximum in (M). *P < 0.05, **P < 0.01, ***P < 0.001 (two-tailed Student's t-test). Dashed lines outline bulge and HG (G, H), SG (I, J) or indicate epidermal-dermal border (K, L). Continuous lines outline dermal papilla. Asterisk marks bulge (H). Arrowheads point at Slc1a3-CreER + cells. Scale bar = 20 lm, except in (H; ORS) scale bar = 40 lm.
Source data are available online for this figure. over distinct niches during growth and identify Slc1a3 as a general marker and effector of activated epithelial stem/progenitor cells throughout the skin.
Results

Differential expression of Slc1a3 during growth and rest
To understand whether growth is coordinated between adjacent epithelial stem cell niches in skin, we quantified cell proliferation in SG and IFE during distinct phases of the hair cycle. Interestingly, we found elevated numbers of Ki67 + proliferating cells in SG and IFE in 2 nd anagen compared to 1 st telogen (growing mice), and also in 3 rd anagen compared to 2 nd telogen (adult mice; Fig 1B and C) , corresponding to growth of SG and IFE (Fig 1D and E) . This suggests that independent of overall growth of the animal, SG and IFE proliferation is correlated to the hair cycle.
Comparing mRNA expression of CD34 + hair follicle stem cells in telogen and anagen, we found increased expression of the glutamate transporter Slc1a3 during anagen ( Fig 1F) . Immunohistochemistry failed to detect Slc1a3 in the hair follicle during telogen (Fig EV1A) , confirming low Slc1a3 expression in quiescent hair follicle stem cells, but revealed expression in the ORS during anagen (Fig EV1B) . Employing Slc1a3-CreER T2 transgenic mice (Slezak et al, 2007) and J, and EV1D and E). In the IFE, Slc1a3 and CreER T2 marked a subset of K5 + basal and most suprabasal cells (Figs 1K and L, and EV1F and G) . Importantly, during anagen-associated growth, the percentage of CreER T2+ SG and IFE basal cells increased compared to telogen (Fig 1M and N) .
Deletion of Slc1a3 delays anagen entry and uncouples SG and IFE growth from the hair cycle
To investigate the functional role of Slc1a3 in hair follicle, SG, and IFE stem cell compartments, we compared Slc1a3 +/À and Slc1a3 À/À siblings (Watase et al, 1998) during the first postnatal hair cycle. Slc1a3 À/À hair follicles did not show differences in either density or hair follicle stem cell marker expression when compared to Slc1a3 +/À littermates (Fig EV2A-C) , excluding major developmental effects on hair follicle stem cell establishment due to abrogation of Slc1a3. However, we found that anagen initiation was significantly delayed in Slc1a3 À/À animals (Fig 2A and B) . At P24, the number of telogen hair follicles was increased whereas the number of hair follicles in anagen II to IV was reduced in Slc1a3 À/À compared to Slc1a3 +/À littermates (Fig 2A and B) , corresponding to an overall shortened hair follicle outgrowth with less Ki67 + cells (Fig 2C and   D , hair follicles contained one pigmented anagen hair shaft consistent with them having entered growth phase (Fig 2I) , indicating that Slc1a3 À/À mice fail to efficiently initiate anagen.
The deficiency in anagen initiation was also pronounced in aged (1.5-2 years old) animals. Aged Slc1a3 +/+ mice presented with more pigmented spots than aged Slc1a3 À/À mice, suggesting that in absence of Slc1a3 normal anagen initiation is disturbed (Fig 2J) . Although the number of hair follicles was maintained ( Fig EV2F) and hair anchoring was not altered in Slc1a3 À/À mice (Fig EV2G) , abrogating Slc1a3 long-term resulted in reduced fur density. Whereas more than 45% of Slc1a3 +/+ hair follicles contained three to four hair shafts, < 10% of Slc1a3 À/À hair follicles consisted of groups of more than two hair shafts (Fig 2K and L) . Together, these data suggest that genetic ablation of Slc1a3 leads to reduced hair follicle stem cell activation and proliferation, consequently resulting in disturbed anagen initiation, impaired hair follicle cycling, and, over time, reduced fur density. Deletion of Slc1a3 also affected SG and IFE growth. The number of dividing basal cells in SG and IFE at P28 was reduced in Slc1a3 À/À animals compared to Slc1a3 +/À littermates although most hair follicles in Slc1a3 À/À mice were in anagen (Fig 2M and N) .
Comparing anagen and telogen regions within each aged animal, we found increased proliferation of SG and IFE basal cells in Slc1a3 +/+ mice during anagen. Intriguingly however, in telogen, SG and IFE proliferation was reduced by 50 and 40%, respectively, in Slc1a3 À/À animals and failed to adjust to the hair cycle (Fig 2O and P) . In line with these observations, SG size and IFE thickness was increased in anagen regions in aged Slc1a3 +/+ mice, but were similar to telogen levels in Slc1a3 À/À mice (Fig 2Q and R) . Together, this shows that deletion of Slc1a3 not only delays hair follicles anagen entry and leads to a diminution of SG and IFE proliferation, but also uncouples SG and IFE proliferation from the hair cycle, resulting in an overall failure of SG and IFE to adjust to the tissue remodeling associated with hair follicle growth. O Basal cell proliferation of the SG in anagen and telogen in aged Slc1a3 +/+ (n = 3, 58 SGs) compared to Slc1a3 À/À (n = 4, 41 SGs) mice. P Basal cell proliferation of the IFE in anagen and telogen in aged Slc1a3 +/+ (n = 4, 11 mm for telogen, 8 mm for anagen) compared to Slc1a3 À/À (n = 3, 12 mm for telogen, 10 mm for anagen) mice. Q
Comparison of SG area between anagen and telogen regions of aged Slc1a3 +/+ (n = 4, 28 SGs for telogen, 25 for anagen) and Slc1a3 À/À (n = 4, 29 SGs for telogen,
Comparison of IFE thickness between anagen and telogen regions of aged Slc1a3 +/+ (n = 6) and Slc1a3 À/À (n = 4) mice.
Data information: Data presented as mean AE SEM in (A, G, H, J, K, M, N, and P). Box-and-whisker plots: midline depicts the median; box depicts 25 th and 75 th percentiles, and whiskers depict the minimum and maximum in (C, D, E, O, Q, and R). *P < 0.05, **P < 0.01, ***P < 0.001, n.s. = not significant (two-tailed Student's t-test in C, D, E, H, J, N-R; Mann-Whitney U-test in A, G, K, M). Dashed lines outline hair follicles (I, L). Scale bar = 100 lm in (B, F) and 30 lm in (I, L). Source data are available online for this figure.
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The EMBO Journal Slc1a3-mediated inter-niche stem cell activation Bettina Reichenbach et al Slc1a3-CreER T2 transgenic mice (Slezak et al, 2007) carrying a Rosa26-YFP reporter allele (Srinivas et al, 2001) . We fate mapped Slc1a3 + hair follicle cells from mid 2 nd anagen (P25/26) and assessed the contribution to telogen follicles after completing one (2 nd telogen, P68) or two hair cycles (3 rd telogen, P117; Fig 3A and B). YFP-labeled hair follicle cells survived catagen and contributed to the new bulge and HG at P68 and P117. Strikingly, the vast majority of HGs and bulges at P117 were YFP + , indicating that Slc1a3-expressing cells labeled at P25/26 include long-term hair follicle stem cells (Fig 3C and D) . To explore the stem/progenitor potential of Slc1a3 + basal cells in the SG we initiated fate mapping during 2 nd telogen (P51-P55) to exclude contribution of hair follicle stem cells (Figs 1G and EV3A; Petersson et al, 2011) . CreER T2 and YFP were not detected in cells around the SG orifice or in the isthmus (Fig EV3B and C) , excluding contributing cells from these sources (Horsley et al, 2006; Snippert et al, 2010a; Page et al, 2013) . Skin was analyzed in 2 nd telogen (P55 and P68), in 3 rd telogen (P116) and 8 months after labeling (Fig 3E) . (Fig 3G and I ). These data show that some Slc1a3 + basal cells are able to renew the entire SG over an extended period of time and support previous reports of the SG as a self-maintained stem cell niche (Fullgrabe et al, 2015 were still present at 8 months after recombination and continuously produced YFP + suprabasal cells (Fig 3J and K) . Over time, the number of YFP + basal cells increased and could be found in clusters of 1-13 YFP + cells (Fig 3L) . Together, these data demonstrate that
Slc1a3 labels a population of long-term stem/progenitor cells, corroborating recent work identifying Slc1a3 as a marker for IFE stem cells (Sada et al, 2016) .
Slc1a3 is transiently expressed in active hair follicle stem cells
Considering the relatively small number of Slc1a3 + stem/progenitor cells labeled in hair follicles, SG, and IFE, we were intrigued by the significant effects genetic abrogation of Slc1a3 had on growth of these stem cell niches. To determine whether Slc1a3 expression is temporally regulated or continuously expressed in individual stem cells, we turned to the ORS, in which most cycling hair follicle stem cells are located, and mapped CreER T2 expression to cell position along the ORS (as quantified from the bulge to the hair follicle base). Comparing anagen stages IIIb, IIIc, IV, and V, we found that the number of CreER T2 expressing cells increased together with the continuous growth of the follicle. While CreER T2+ cells could be localized starting from the first position below the bulge (+1), the density was highest in the middle of the ORS at all four stages (Fig 4A) . This dynamic distribution of Slc1a3 + cells along the ORS offered a temporal resolution that we exploited. We fate mapped Slc1a3 + hair follicle cells from mid-(P25/26) or late (P29/30)
anagen and assessed the contribution to full-grown follicles at P35
and to telogen follicles at P68 (Fig 4B) . Hair follicles of P30 mice were more progressed in anagen compared to hair follicles of P25/ P26 mice (Fig 4C) . Fate mapping to full-grown follicles (P35) revealed contribution of Slc1a3 + cells to matrix and inner differentiated layers. Progeny of Slc1a3 + cells labeled at mid-anagen contributed significantly more often to higher matrix positions and to the inner root sheath and hair shaft lineages than progeny of late anagen Slc1a3-targeted cells (Fig 4D-H . Similarly, the majority of cells in S-phase (76 AE 6%; labeled by injection of the nucleotide analog EdU 2 h before sacrifice) were CreER T2+ (Fig 4K) .
Together, these results show that Slc1a3-CreER T2 expression is associated with proliferation. (Fig 5A-C) , showing that previously Slc1a3-expressing basal cells had lost Slc1a3 expression, whereas others upregulated Slc1a3. Importantly, the ratio of proliferating Ki67 + cells that co-expressed CreER T2 remained constant in telogen and anagen (Fig 5D) . 
I-L Representative micrographs (I) and quantification of proliferating cells in ORS (J), SG (K) and IFE (L) of Rasless mice (n = 3, 22
HFs, 52 SGs and 7 mm IFE, respectively), in which mitosis was inhibited in Slc1a3-CreER T2+ cells, compared to control (ORS n = 3, 18 HFs; SG and IFE n = 4, 65 SGs and 10 mm IFE, respectively).
M, N Quantification of percentage of Slc1a3-CreER T2+ HFs in 30 lm sections in non-induced anagen (anagen I, n = 2, 18 HFs; anagen II, n = 2, 39 HFs; anagen III-IV, n = 3, 60 HFs) and depilation (anagen I, n = 3, 60 HFs; anagen II, n = 3, 56 HFs; anagen III-IV, n = 4, 119 HFs; M) and representative micrographs of Slc1a3-CreER T2 and Ki67 in depilated HFs (N).
O Hair follicle stage distribution 5 days after depilation in Slc1a3 +/À (n = 3, 45 HFs) compared to Slc1a3 À/À (n = 3, 60 HFs) mice. P = 0.1644 derived from grouped comparison of ranked HF stages in Slc1a3 +/À and Slc1a3 À/À mice. P Slc1a3 mRNA expression in hair follicle stem cells (HFSCs) after passage 1 and passage 3 compared to expression in vivo. Q Slc1a3 mRNA expression in basal IFE cells in culture compared to expression in vivo. R Slc1a3 mRNA expression in mouse primary keratinocytes after overexpression of hSlc1a3 (+Dox; n = 3 repeats) compared to control (ÀDox; n = 3 repeats). S Percentage of proliferating PH3 + mouse primary keratinocytes expressing hSlc1a3 (+Dox; n = 18 technical replicates) compared to control (ÀDox; n = 18 technical replicates).
Data information: Data are mean AE SEM in (B, C, D, F, G, H, L, M, O, R and S)
; box-and-whisker plots: midline depicts the median; box depicts 25 th and 75 th percentiles;
whiskers depict minimum and maximum in (J and K); *P < 0.05, **P < 0.01, ***P < 0.001, n.s. = not significant (two-tailed Student's t-test, except Mann-Whitney U-test Source data are available online for this figure.
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The EMBO Journal e98280 | 2018 ª 2018 The Authors Ras genes after recombination (Fig EV4C) . Ras genes are obligatory for cell cycle progression and mitosis, so deleting all Ras genes in Slc1a3 + cells abrogates their proliferation (Göritz et al, 2011) . Tamoxifen-induced recombination of Slc1a3-Rasless mice during anagen (P23-29) almost completely abrogated ORS proliferation (Fig 5I and J) and significantly reduced the number of Ki67 + cells in SG and IFE (Figs 5K and L, and EV4D and E), analyzed at P30. In all three niches, proliferation was reduced to a much larger extent than the co-expression of Ki67 and CreER T2 at a specific time point would have suggested, validating the transient Slc1a3 expression in actively cycling stem/progenitor cells in hair follicle, SG, and IFE.
Injury-induced stem cell activation is Slc1a3 independent
Depilation is considered as a mild injury, leading to hair follicle stem cell proliferation and hair growth. We investigated Slc1a3-CreER T2 expression after depilation-induced injury and discovered that in contrast to growth-induced stem cell activation, hair follicle stem cells do not upregulate Slc1a3 after injury. After depilation, hair follicle stem cells in anagen I and II show significantly reduced CreER T2 expression when compared to non-induced anagen hair follicles. Interestingly, during anagen III-IV a normal morphology and proliferation pattern is reestablished and CreER T2 is expressed in the ORS of depilated and non-induced anagen hair follicles alike (Fig 5M and N) . To address the functional role of Slc1a3 in depilation-induced anagen, we analyzed Slc1a3 +/À and Slc1a3 À/À hair follicles 5 days after depilation. In contrast to noninduced anagen (Fig 2A-G) , the absence of Slc1a3 did not affect the growth of the depilation-induced new hair follicle (Fig 5O) . (Fig 5P and Q) . Re-expression of Slc1a3 in cultured primary mouse keratinocytes (Fig 5R) resulted in reduced proliferation (Fig 5S) . These results suggest Slc1a3 acts as a cell-autonomous modulator of epidermal stem cell activation during growth and homeostasis, but not after wounding.
Slc1a3 acts in conjunction with mGluR5
The function of Slc1a3 in the nervous system is to buffer and clear extracellular glutamate in the proximity of glutamate receptors to regulate local glutamate abundance and receptor excitability (Huang et al, 2004; Tzingounis & Wadiche, 2007; Divito & Underhill, 2014) . We found mRNA expression of the metabotropic glutamate receptor mGluR5 both during anagen and telogen (Fig 6A) . Immunohistochemistry localized mGluR5 expression to telogen and anagen hair follicle, HG, SG, and IFE as well as to the ORS during anagen, partly co-localizing with Slc1a3 in all three niches (Fig 6B-D) .
To test for a co-dependence of Slc1a3 and mGluR5, we topically treated mice with the mGluR5 allosteric antagonist MTEP at the beginning of anagen (P22-P25) and staged hair follicles directly after (P26). MTEP treatment delayed anagen stage progression compared to vehicle-treated animals (Fig 7A) . Topical treatment with the competitive Slc1a3 inhibitor DL-TBOA caused a similar delay in anagen progression (Fig 7B) , which was comparable to the phenotype observed in Slc1a3 À/À mice (Fig 2A and G) . Combined application of MTEP and DL-TBOA did not exceed the effect of single compounds, suggesting that Slc1a3 and mGluR5 act on the same pathway ( Fig 7C) . Furthermore, treatment of Slc1a3 À/À mice with MTEP had no effect on anagen progression beyond the Slc1a3 À/À phenotype alone (Fig EV5A) , further strengthening the conclusion of Slc1a3 and mGluR5 cooperation. Treatment with L-glutamate only slightly expedited anagen entry compared to vehicle-treated animals ( Fig EV5B) . Moreover, we found that blocking mGluR5 or Slc1a3 significantly reduced anagen-induced growth of SG and IFE. Source data are available online for this figure. ª 2018 The Authors The EMBO Journal e98280 | 2018 (Fig 7D-G ) and no effect of MTEP on Slc1a3 À/À mice (Fig EV5C-F) .
Application of L-glutamate did not significantly influence SG and IFE growth (Fig EV5G-J) . These data imply that Slc1a3 acts in conjunction with mGluR5.
Discussion
We report that skin growth is mediated through coordinated stem/ progenitor cell proliferation in three distinct epithelial stem cell niches. As hair follicle stem cells transition from quiescence to activation, their proliferative burst is mirrored by the proliferative kinetics of IFE and SG. We identified the glutamate transporter Slc1a3 as a general marker and effector of activated epithelial stem cells throughout the skin. Each niche has a distinct ratio of proliferating to Slc1a3-expressing cells, which remains constant during growth and homeostasis. Such a system enables each individual niche to maintain its characteristics while expanding in synchrony with surrounding niches. Neural stem cells express Slc1a3 and mGluR5 (Shibata et al, 1997; Mori et al, 2006; Slezak et al, 2007; Gilley & Kernie, 2011; Nochi et al, 2012) , and in Drosophila, dietary L-glutamate stimulates intestinal stem cell division and gut growth via the metabotropic glutamate receptor (Deng et al, 2015) , suggesting that niche-spanning stem cell activation could be a general mechanism. In conclusion, our data reveal new properties of epithelial tissue growth and a role for Slc1a3 in inter-niche modulation of stem/progenitor cell activation.
Slc1a3 is transiently expressed in activated stem cells
We identified the glutamate transporter Slc1a3 as highly enriched in a subset of activated hair follicle stem cells when compared to their quiescent counterparts. Furthermore, a distinct subset of basal SG and IFE cells expressed Slc1a3 (Figs 1 and EV1 ).
We discovered that stem cell niches in the skin require Slc1a3 for their coordinated growth. When Slc1a3 was ablated, the hair cycle was delayed and proliferation rates decreased (Fig 2A-G) . With time, the absence of Slc1a3 resulted in a thinning of the hair coat, suggesting an accumulative effect of failing to properly initiate hair follicle cycling (Figs 2J-L and EV2F). Additionally, Slc1a3 ablation resulted in reduced SG and IFE proliferation but also, importantly, a failure to respond to the activation signals that normally couple these niche proliferation patterns to the hair cycle. As a consequence, aged mice lacking Slc1a3 developed smaller SGs and thinner IFE (Fig 2M-R) . This enhanced aging phenotype is similar to human skin aging, but the opposite of aging phenotypes observed in, for example, circadian clock abrogation (Janich et al, 2011) . It will be important to determine whether increased Slc1a3 function would rejuvenate skin.
At first, we were puzzled by the severe consequences of ablating Slc1a3 in a small subset of epithelial cells, but tracing of progeny derived from Slc1a3-expressing cells showed that Slc1a3 marked a subset of stem/progenitor cells in all compartments (Figs 3 and  EV3) . During anagen progression, Slc1a3 expression is transiently detected in defined subpopulations of hair follicle stem cells. We detected the same transitory expression of Slc1a3 in both SG and IFE when following recombined YFP + basal cells over time and determining the fraction also expressing CreER
T2
, indicative of their Slc1a3 expression (Figs 4A and 5A-C and E-G). In both SG and IFE, we found that the increase in proliferation detected as the skin transitions from telogen to anagen arose from the Slc1a3 + population, suggesting that Slc1a3 is a marker or inducer of an activated stem and progenitor cell state. Interestingly however, the ratio of CreER T2+ cells contained within the cycling Ki67-expressing population varied between niches (Fig 5D and H A-C Quantification of hair cycle progression assessed by hair follicle staging following topical treatment with mGluR5 antagonist MTEP (n = 5, 75 HFs; A), Slc1a3-antagonist DL-TBOA (n = 4, 60 HFs; B) or combined MTEP and DL-TBOA treatment (n = 4, 60 HFs; C) in comparison with vehicletreated mice (n = 5, 75 HFs; n = 3, 60 HFs; n = 3 60 HFs, respectively). P < 0.0001 derived from grouped comparison of ranked HF stages in mice treated with vehicle and antagonist. D-G Quantification of anagen-induced proliferation (D, F) and growth (E, G) of SG (D, E) and IFE (F, G) following topical treatment with MTEP (n = 4, 29 SGs and 10 mm, respectively), DL-TBOA (n = 5, 38 SGs and n = 6, 10 mm), or MTEP + DL-TBOA (n = 4, 38 SGs and 12 mm, respectively) relative to vehicle (n = 9, 72 SGs and 20 mm, respectively). P-values derived from comparison of the mean induced proliferation and growth of SG and IFE in mice treated with vehicle and antagonist. Graph shows the percentage change normalized to the vehicle group.
Data information: Data are mean AE SEM; *P < 0.05, **P < 0.01, ***P < 0.001,
Source data are available online for this figure. the ORS and dramatically reduced proliferation in the SG and IFE. The reduction in proliferation exceeds predictions based on Ki67 and static CreER expression (Figs 5I-L and EV4), and further supports the transient nature of Slc1a3-expression.
Behavior of activated stem cells
In the ORS, Slc1a3 + cells were both spatially and temporally regulated and this correlated with their fate. Slc1a3 + cells in the ORS contributed to the matrix and inner differentiated layers of the hair follicle in mid-and late anagen (Fig 4A-H) , in contrast to the expansion of the activated HG, which drives matrix formation in early anagen (Rompolas et al, 2013) . However, we also found that the ORS fate was correlated with the temporal regulation of Slc1a3 expression along the hair follicle. This finding is intriguing in light of previous work correlating the potential of ORS cells and their cycling behavior (Hsu et al, 2011) . It is interesting that we did not detect any Slc1a3 expression in hair bulb transit amplifying cells, perhaps a reflection of their short-lived nature or their rapid proliferation. Furthermore, Slc1a3-expression remains low in hair follicle and IFE stem/progenitor cells after wounding such as depilation-induced hair growth or cell culture (Fig 5M, N, P and Q) , and reintroduction of Slc1a3 in cultured keratinocytes negatively affects their proliferation (Fig 5S) . It is tempting to speculate that glutamate signaling, through regulation of Slc1a3 expression, modulates the activated stem cell state during tissue growth and homeostasis while hyperproliferation of hair follicle transit amplifying cells or hair follicle stem cell proliferation as a response to injury, is Slc1a3-independent and regulated by other mechanisms. Using a different Slc1a3-CreER T2 mouse line, a recent study reported selective targeting of the inner root sheath in the anagen follicle (Sada et al, 2017) . We could detect neither Slc1a3 nor CreER T2 protein expression in the inner root sheath but only in the outer root sheath, indicating that the line used by Sada et al does not recapitulate the endogenous expression faithfully.
Slc1a3 labels long-term contributing stem and progenitor cells in three epithelial compartments
We used lineage tracing to examine stem cell potential in Slc1a3-expressing cells. We targeted Slc1a3 + cells in the ORS at 2 nd anagen (P25/26) and traced them over two consecutive hair cycles to P68 and P117. The vast majority of analyzed hair follicles contained YFP + daughter cells contributing to the new bulge and HG, demonstrating long-term stem cell potential of targeted ORS cells (Fig 3A-D) . The identity and location of SG progenitor cells have been much debated (Horsley et al, 2006; Jensen et al, 2009; Kretzschmar et al, 2014; Fullgrabe et al, 2015) . Recombined Slc1a3 + , YFP + cells in the SG basal layer generate differentiated progeny and expand the YFP + basal cell population (Fig 3G-I ).
Some Slc1a3 Clonal analysis from cells targeted for recombination using Slc1a3-CreER T2 in the IFE showed that the majority of clusters were maintained over time, with the vast majority of clones producing differentiated progeny 8 months after tamoxifen (Fig 3K and L) . However, the clones varied dramatically in size, with some single basal cell clones being maintained for up to 8 months, whereas others readily expanded laterally. These data demonstrate that Slc1a3 + stem cells differ in their spatial restrictions. Furthermore, it unveils a novel feature of IFE stem cells, identifying a subset of Slc1a3 + basal cells that only generate suprabasal progeny without expanding laterally during homeostasis.
Glutamate signaling in stem cell niches
We identified mGluR5 as a constitutively expressed interaction partner for Slc1a3 in the skin epithelia (Fig 6) . Strikingly, inhibition of mGluR5 phenocopies the effects seen in Slc1a3 À/À ( M, N, , while Slc1a3 À/À mice are refractory to mGluR5 inhibition ( Fig EV5A and C-F) .
In skin, glutamate is released by keratinocytes and is increased in the basal layer by disruption of the outer epithelial layer (Nordlind et al, 1993; Fuziwara et al, 2003) . Macrophages located in epidermis and dermis also release glutamate, and this increases in response to inflammation (Nordlind et al, 1993; Zhao et al, 2004) . In Drosophila, dietary L-glutamate stimulates intestinal stem cell division and gut growth via the metabotropic glutamate receptor (Deng et al, 2015) , showing that extracellular glutamate can influence stem cell proliferation. However, application of L-glutamate did not significantly affect anagen onset or SG and IFE proliferation (Fig EV5B and G-J) , suggesting that extracellular glutamate is abundant in the skin.
Neural stem cells in the developing cerebral cortex and adult hippocampus express Slc1a3 (Mori et al, 2006) . While it is known that injury increases Slc1a3 expression in adult hippocampal stem cells (Gilley & Kernie, 2011) , the in vivo function of Slc1a3 in neural stem cells is still unknown. However, deletion of Slc1a3 in cultured neural stem cells alters proliferation and neurosphere formation in an mGluR5-dependent manner (Gilley & Kernie, 2011) . Melanocytes express mGluR5 and overexpression induces melanoma formation in vivo (Choi et al, 2011) , indicating a role in regulation of proliferation. A role for glutamate signaling in regulating stem cell proliferation is beginning to appear, but it is clear that the cellular outcome is context dependent. It is tempting to speculate that glutamate release from keratinocytes and macrophages could stimulate mGluR5-dependent stem cell activation; however, our data imply that mGluR5 activity is gated by other factors. Slc1a3 could play such a role by increasing the receptor deactivation rate. Another possible interpretation is that low receptor activity is important for stem cell activation and that no or high activity both could lead to quiescence. By temporally regulating the Slc1a3 expression in a subpopulation of stem and progenitor cells in the constitutive presence of the glutamate receptor, each stem cell niche creates an elegant and highly dynamic signaling mechanism, which allows stem cells to rapidly respond to environmental cues. Here, we propose a modulatory role for Slc1a3 in stem and progenitor cell activation during growth and homeostasis, distinct from the proliferative burst initiated by an acute injury.
Materials and Methods
Mice and lineage-tracing experiments
Slc1a3-CreER T2 (Slezak et al, 2007) were crossed to Rosa26-YFP reporter (Srinivas et al, 2001) localization. The thymidine analogue 5-ethynyl-2 0 -deoxyuridine (EdU) was administered by intraperitoneal injection 2 h before perfusion. Slc1a3 À/À mice were described previously (Watase et al, 1998) , and Slc1a3 tm1.1(KOMP)Mbp was purchased from the KOMP Repository (MGI ID = MGI:5443926). Animal experiments were carried out in accordance to Swedish and European law and approved by Jordbruksverket.
Topical pharmacological treatment
The lower back of female mice was shaved, and 50 ll of the respective compound or vehicle was applied twice per day for 4 days, starting at P22. The following compounds were applied: DL-TBOA (21 mM in DMSO; Tocris) and MTEP (15 mM in DMSO; Abcam).
L-Glutamate (2.5%; L-glutamic acid; Sigma) was applied in a cutaneous emulsion (Propyless, containing 20% propylene glycol and 9% fat; Merck Sharp & Dome).
Depilation and hair plucking
Depilation of the lower back of mice was done using Veet Warm Wax. Hair was plucked from the lower back and fixed in 4% formaldehyde solution before immunohistochemistry.
Histology and immunohistochemistry
Mice were perfused and postfixed with 4% formaldehyde solution. Caudal back skin was cryopreserved in 30% sucrose and embedded in OCT for sagittal or horizontal (12 or 30 lm) cryosectioning. For histological analysis, sections were stained with hematoxylin and eosin. For immunohistochemistry, sections were permeabilized and blocked for 45-60 min with 10% normal donkey serum, 0.3% Triton in PBS followed by primary and species-specific fluorophoreconjugated secondary antibody incubation. Antibodies were diluted in 10% normal donkey serum in PBS. Biotinylated primary antibodies were detected with a Cy3-conjugated streptavidin (Jackson laboratories). For Cre and Loricrin co-labeling, immunostaining for Cre was completed after which slides were blocked with 10% rabbit serum followed by Loricrin labeling using a directly fluorophoreconjugated anti-Loricrin antibody (Zenon â antibody labeling kit, Thermo Fisher Scientific). The following primary antibodies were used: CD34 (rat, 1:50; Abcam #ab8158), Cre (rabbit, 1:3,000; generous gift from Günther Schütz Heidelberg or rabbit, 1:500; Cell Signaling #15036), FABP5 (goat biotinylated, 1:1,000-1:4,000; R&D Systems #BAF1476), Loricrin (rabbit, 1:1,000; Abcam #ab24722), Ki67 (rat, 1:2,000; eBioscience #14-56898 or rabbit, 1:250-1:500; Thermo Scientific #RM-9106), K5 (Cytokeratin 5; rabbit, 1:1,000; Abcam #ab52635 or guinea pig, 1:1,000; Acris #BP5006), K6 (Cytokeratin 6; rabbit, 1:2,000; Abcam #ab24646), mGluR5 (rabbit, 1:250; Abcam #ab53090), P-cadherin (rat, 1:50; Invitrogen #12-2000Z), PH3 (Histone H3 pS10; rabbit, 1:1,000; Abcam #ab5176), Slc1a3 (Glast; guinea pig, 1:500; Frontier Institute #GLAST-GP-Af1000), Sox9 (goat, 1:500; R&D Systems #AF3075), and GFP (chicken, 1:4,000; Aves Lab #GFP-1020 or goat, 1:1,000; FITC-labeled; Abcam #ab6662).
Images were acquired with a Leica SP8X or a Zeiss LSM700 confocal microscope. Quantifications were performed on overview and high-resolution images using Image J/Fiji software.
Hair cycle staging
Hair cycle phases and anagen stages were determined according to morphological criteria previously described (Muller-Rover et al, 2001) . For quantitative purposes, 15-20 vertically sectioned hair follicles from the lower back were staged per animal. Siblings, including both male and female mice, were analyzed, except for topical pharmacological treatments, where only females were treated and quantified.
Quantifications and statistical analysis
All quantifications were performed in mixed groups of male and female mice except for topical pharmacological treatments, where only females were treated and quantified.
Quantifications of 1 st telogen were performed at P22-P24. Quantifications of 2 nd anagen were performed in hair follicle stages III-IV (mid-anagen) at P25-P26. Quantifications of catagen were performed at P40. Quantifications of 2 nd telogen were performed at P49, P55, P58, and P68. Quantifications of 3 rd anagen were performed at P89.
Quantifications of early anagen were performed at P24 or P102. In the IFE, thickness was measured from the basal cell layer to and including Loricrin + suprabasal cells.
Sample sizes were not predetermined using statistical methods but were based on previous experience. Data are presented as mean AE standard error of mean (SEM) or AE SEM. In some graphs, individual data points are plotted. Sample sizes (n) are indicated in the Figure legends. Data analysis and statistics were performed using GraphPad Prism or Excel. Mann-Whitney U-tests for general differences of hair follicle stages in Slc1a3 +/À and Slc1a3 À/À animals and upon cutaneous treatment were performed on ranked hair follicle stages in the different animal groups.
Overexpression of hSlc1a3 in keratinocytes
Mouse primary keratinocytes were infected with a lentiviral pCW57.1 vector (Addgene #41393) expressing hSlc1a3 under a doxycycline-inducible promoter. Infected cells were selected using puromycin for 7 days, after which doxycycline was administered for 3 days.
Skin dissociation and fluorescence-activated cell sorting
For isolation of cells in telogen, postnatal mouse skin was dissected and adipose tissue was scraped off. Remaining skin was digested in 0.05% trypsin (GIBCO) and incubated for 30 min at 37°C. Cells were scraped off from the epidermal side, filtered through strainers (70, 40 lm) and pelleted. For isolation of cells in anagen, skin was placed in Collagenase (5 mg/ml in HBSS; Sigma) and incubated for 1 h at 37°C. Cells were scraped off from the dermal side and incubated in 0.05% trypsin (GIBCO) for 10-15 min at 37°C. The cell suspension was filtered through strainers (70, 40 lm) and pelleted. The single-cell suspensions were incubated with the respective antibodies for 30 min on ice. The following antibodies were used: CD34-A700 (rat, 1:100; eBioscience #56-0341-82), CD49f (Integrin alpha 6)-PE (rat, 1:1,000; eBioscience #12-0495-81), Sca1-PerCP-Cy5.5 (rat, 1:500; eBioscience #45-5981). After sorting, the CD34 + /CD49f + /Sca1-hair follicle bulge cells were purified using a Becton Dickinson FACS Aria flow cytometer with the FACSDiva software (BD Biosciences). Purity of the sorted population was validated with RT-qPCR for CD34 and Sca1 expression.
Quantitative reverse transcription PCR (RT-qPCR)
Total RNA was isolated from FACS-sorted cells using Trizol-LS (Life Technologies) followed by RNA extraction: The RNA phase was separated by mixing the isolated cells with chloroform; for RNA precipitation, EtOH was added to the sample before loading it onto RNEasy columns and processing according to the protocol (RNEasy Mini Kit, Qiagen).
For RNA extraction from whole skin, the Direct-zol TM RNA MiniPrep Kit (Zymo Research) was used. RNA was reverse-transcribed using the SuperScript â VILO cDNA Synthesis Kit (Invitrogen). RTqPCR was conducted using a 7500 Fast Real-time PCR System from Applied Biosystems and Fast CYBR â Green Master Mix (Life Technologies). Mouse Hprt was used as endogenous control. Relative expression was calculated as dCt. Fold change in mRNA levels was calculated as 2 ddCt . Primers used are listed below. The RT-qPCR for Slc1a3 analysis was performed with pooled samples obtained from seven animals in telogen and four animals in anagen. The RT-qPCR was performed using triplicates in two technical replicates. The RT-qPCR for mGluR5 analysis was performed comparing samples from four mice for telogen and anagen each. Each RT-qPCR was performed as triplicates.
Primers (and their sequences) used for RT-qPCR were HPRT-F (tcagtcaacgggggacataaa), HPRT-R (ggggctgtactgcttaaccag), HSLC1A3-F (tacgagtgacagctgcagat), HSLC1A3-R (tccatggcctcagacacatt), MGLUR5-F (agaaacccatagtgggagtcat), MGLUR5-R (atgctagttgcagagtaagcaat), SLC1A3-F (ccaaaagcaacggagaagag), and SLC1A3-R (acctcccggtagc tcatttt).
Expanded View for this article is available online.
